RATIONALE: Nitric oxide bioactivity, mediated through the formation of S-nitrosothiols (SNOs), has a significant effect on bronchomotor tone. S-Nitrosoglutathione is an endogenous bronchodilator that is decreased in children with asthmatic respiratory failure and in adults with asthma undergoing segmental airway challenge. Recently we showed that S-nitrosoglutathione reductase (GSNOR) regulates endogenous SNOs. Mice with genetic deletion of GSNOR are protected from airway hyperresponsivity in an allergic asthma model. OBJECTIVES: We hypothesized that GSNOR is increased in human asthma and correlates with lung SNO content and airway reactivity. METHODS: We recruited 36 subjects with mild asthma with FEV(1) 88.5 +/- 2.3% predicted and 34 healthy control subjects with FEV(1) 100.7 +/- 2.5% predicted. Bronchoalveolar lavage (BAL) was performed in all subjects. Cell counts, differentials, GSNOR activity, and SNO levels were determined in BAL. MEASUREMENTS AND MAIN RESULTS: SNO content was decreased in asthmatic BAL compared with control BAL and correlated inversely with GSNOR expression in BAL cell lysates. Furthermore, GSNOR activity measured from BAL samples was significantly increased in subjects with asthma compared with control subjects and correlated inversely with the provocative concentration of methacholine causing a 20% decrease in FEV(1). CONCLUSIONS: These findings suggest that GSNOR is an important regulator of airway SNO content and airways hyperresponsiveness in human asthma.
RATIONALE: Nitric oxide bioactivity, mediated through the formation of S-nitrosothiols (SNOs), has a significant effect on bronchomotor tone. S-Nitrosoglutathione is an endogenous bronchodilator that is decreased in children with asthmatic respiratory failure and in adults with asthma undergoing segmental airway challenge. Recently we showed that S-nitrosoglutathione reductase (GSNOR) regulates endogenous SNOs. Mice with genetic deletion of GSNOR are protected from airway hyperresponsivity in an allergic asthma model. OBJECTIVES: We hypothesized that GSNOR is increased in humanasthma and correlates with lung SNO content and airway reactivity. METHODS: We recruited 36 subjects with mild asthma with FEV(1) 88.5 +/- 2.3% predicted and 34 healthy control subjects with FEV(1) 100.7 +/- 2.5% predicted. Bronchoalveolar lavage (BAL) was performed in all subjects. Cell counts, differentials, GSNOR activity, and SNO levels were determined in BAL. MEASUREMENTS AND MAIN RESULTS:SNO content was decreased in asthmatic BAL compared with control BAL and correlated inversely with GSNOR expression in BAL cell lysates. Furthermore, GSNOR activity measured from BAL samples was significantly increased in subjects with asthma compared with control subjects and correlated inversely with the provocative concentration of methacholine causing a 20% decrease in FEV(1). CONCLUSIONS: These findings suggest that GSNOR is an important regulator of airway SNO content and airways hyperresponsiveness in humanasthma.
Authors: F H Guo; S A Comhair; S Zheng; R A Dweik; N T Eissa; M J Thomassen; W Calhoun; S C Erzurum Journal: J Immunol Date: 2000-06-01 Impact factor: 5.422
Authors: R A Dweik; S A Comhair; B Gaston; F B Thunnissen; C Farver; M J Thomassen; M Kavuru; J Hammel; H M Abu-Soud; S C Erzurum Journal: Proc Natl Acad Sci U S A Date: 2001-02-20 Impact factor: 11.205
Authors: Joel Schwartz; Christian Schindler; Elisabeth Zemp; André P Perruchoud; Jean-Pierre Zellweger; Brunello Wüthrich; Philippe Leuenberger; Ursula Ackermann-Liebrich Journal: Chest Date: 2002-09 Impact factor: 9.410
Authors: Josephine Hjoberg; Stephanie Shore; Lester Kobzik; Shoji Okinaga; Arlene Hallock; Joseph Vallone; Venkat Subramaniam; George T De Sanctis; Jack A Elias; Jeffrey M Drazen; Eric S Silverman Journal: J Appl Physiol (1985) Date: 2004-03-12
Authors: Hao Wu; Isabelle Romieu; Juan-Jose Sienra-Monge; Blanca Estela Del Rio-Navarro; Daniel M Anderson; Charlotte A Jenchura; Huiling Li; Matiana Ramirez-Aguilar; Irma Del Carmen Lara-Sanchez; Stephanie J London Journal: J Allergy Clin Immunol Date: 2007-06-01 Impact factor: 10.793
Authors: Shweta Choudhry; Loretta G Que; Zhonghui Yang; Limin Liu; Celeste Eng; Sung O Kim; Gunjan Kumar; Shannon Thyne; Rocio Chapela; Jose R Rodriguez-Santana; William Rodriguez-Cintron; Pedro C Avila; Jonathan S Stamler; Esteban G Burchard Journal: Pharmacogenet Genomics Date: 2010-06 Impact factor: 2.089
Authors: Thomas M Raffay; Koby Bonilla-Fernandez; Anjum Jafri; Ramadan B Sopi; Laura A Smith; Feifei Cui; Maureen O'Reilly; Rongli Zhang; Craig A Hodges; Peter M MacFarlane; Gail Deutsch; Richard J Martin; Benjamin Gaston Journal: Am J Respir Cell Mol Biol Date: 2021-07 Impact factor: 6.914
Authors: Nadzeya V Marozkina; Christina Wei; Sean Yemen; Horst Wallrabe; Alykhan S Nagji; Lei Liu; Tatiana Morozkina; David R Jones; Benjamin Gaston Journal: Am J Respir Cell Mol Biol Date: 2012-01 Impact factor: 6.914
Authors: Jay R Laver; Tânia M Stevanin; Sarah L Messenger; Amy Dehn Lunn; Margaret E Lee; James W B Moir; Robert K Poole; Robert C Read Journal: FASEB J Date: 2009-08-31 Impact factor: 5.191